Abeona Therapeutics Inc (ABEO) stock news · rev $5.8M
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
This ABEO news page leads with what Abeona Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ABEO yet. We will not pad this page with generic market recap.
Latest reported ABEO revenue for 2025-12-31 was $5.8M. Net income was $71.2M. Revenue was up 37.1% from 2024-12-31 to 2025-12-31. ABEO currently screens at market cap $301.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ABEO stock page; for the tape open the quote page.
ABEO stock news FAQ
What are ABEO's latest revenue and net income?
Latest cached Abeona Therapeutics Inc (ABEO) revenue for Dec 31, 2025 was $5.8M. Net income was $71.2M. Statements: https://lician.com/financials/abeo
How did ABEO revenue change from the prior cached period?
Cached Abeona Therapeutics Inc (ABEO) revenue was up 37.1% from $4.2M (Dec 31, 2024) to $5.8M (Dec 31, 2025). Statements: https://lician.com/financials/abeo
What is ABEO's market cap?
Abeona Therapeutics Inc (ABEO) market cap is $301.8M on the latest cached fundamentals snapshot.
What kind of company is ABEO?
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Where is ABEO stock news listed?
Cached stock news for Abeona Therapeutics Inc (ABEO) is listed at https://lician.com/news/abeo. Filings: https://lician.com/sec/abeo
Not investment advice.